2015 - 2016 Advisory Committee

Expert Advisors


Overseas Experts:

Prof. Debiao Li is a world-renown MRI physicist. He received Ph.D. in Biomedical Engineering from the University of Virginia in 1992. He served as Assistant Professor of Radiology at Washington University, St. Louis, tenured Professor of Radiology and Biomedical Engineering at Northwestern University, Chicago, and Director of Cardiovascular Magnetic Resonance Center. Currently he is the Director of Institute of Biomedical Imaging Institute at Cedars-Sinai Medical Center, Los Angeles, and Professor of the University of California Los Angeles (UCLA) in Medicine and Bioengineering. Prof. Li has been in cardiovascular magnetic resonance research for more than twenty years, published more than 180 papers, received over $20 million in NIH research grants. He has made pioneering contributions in coronary MR angiography, vascular plaque imaging, myocardial perfusion imaging, and non-contrast magnetic resonance angiography. Prof. Li served as the President of the International Society of Magnetic Resonance in Medicine (ISMRM), the President of International Magnetic Resonance Angiography Working Group, board of the Society for Cardiovascular Magnetic Resonance (SCMR), President of the Overseas Chinese Society of Magnetic Resonance (OCSMRM). He is the deputy editor of Magnetic Resonance in Medicine and Journal of Magnetic Resonance Imaging. He is Fellow of ISMRM and American Institute for Medical and Biological Engineering.

Prof. Graham Wright received his Ph.D. in Electrical Engineering from Stanford University, US in 1991. He is currently the Director of the Schulich Heart Research Program at Sunnybrook Health Sciences Centre, a senior scientist at Sunnybrook Research Institute, and a professor in the Department of Medical Biophysics at the University of Toronto. Dr. Wright was appointed the Canada Research Chair in Imaging for Cardiovascular Therapeutics in 2010. He also recently served as President of the International MR Angiography Club and Chair of the Interventional Study Group of the International Society of Magnetic Resonance in Medicine. The research focus of Dr. Wright’s group is cardiovascular imaging, with an emphasis on MRI. This effort includes basic biophysics to characterize the relationship between MR signals and underlying pathophysiology in blood and tissue; engineering to develop more effective methods and devices to acquire, analyze, and visualize medical images; and application of these tools to assessment, treatment planning, and therapy guidance in ischemic and structural heart diseases, complex arrhythmias, and peripheral vascular diseases. Together with trainees and collaborators, he has published over 152 peer-reviewed papers and 420 conference abstracts, which have garnered numerous awards and resulted in 20 patents. For this work, he has received substantial peer-reviewed infrastructure and operating grant funding.

Prof. Chun Yuan specializes in magnetic resonance imaging (MRI) physics and technology, particularly in the areas of cardiovascular imaging. He is a Professor in the Departments of Radiology and Bioengineering at the University of Washington, director of the Bio-Molecular Imaging Center. Dr. Yuan is also the co-director of the Vascular Imaging Lab (VIL), which is recognized internationally for developing innovative MRI techniques for the quantitative analysis of vulnerable atherosclerotic plaques. He is also the honorary director of the Center for Biomedical Imaging Research of Tsinghua University in Beijing, China. He received his B.Sc. in Physics from the Beijing Normal University in 1982 and Ph.D. in Biomedical Physics from the University of Utah in 1988. From 1996-2000 Dr. Yuan received the NIH National Heart, Lung, and Blood Institute Research Career Development Award. He is also a founding member of the Society for Cardiovascular Magnetic Resonance. He served in the ISMRM Award Committee from 2011-2014 and was the president of Overseas Chinese Society of Magnetic Resonance in Medicine in 2012. He serves on the program committee of the AHA Radiology Council. He is a fellow of ISMRM and AHA. His career has been focused on developing novel imaging techniques for the diagnosis and treatment of high risk atherosclerotic lesions. He has been the PI of numerous NIH R01 grants focusing on the development of novel MRI based techniques for plaque imaging, their validation, and risk assessment based on the plaque features that can be identified by MRI. A major outcome is the identification of key plaque features associated clinical symptoms: intraplaque hemorrhage, lipid-rich necrotic core, and luminal ulceration (and/or disruption). He has over 200 journal publications.

Note:overseas experts are listed fully in alphabetical order according to the expert's last name
        

Domestic Experts:

Prof. Fabao Gao, M.D., a professor in the Department of Radiology, Director of the Molecular Imaging Laboratory, in West China Hospital of Sichuan University. He is also the vice chairman of molecular imaging section of Biophysical Society of China, vice head of molecular imaging section of Chinese society of radiology, editor of International Journal of Magnetic Resonance Imaging and Chinese Journal of Nuclear Medicine and Molecular Imaging. His research focuses on cardiovascular imaging and molecular imaging. He published more than 80 peer-reviewed papers. Since 1998, he has incorporated in one National Basic Research Program (973 Program), one National Key Technology Research and Development Program of China during the “12th Five-Year Plan”, 6 programs of National Natural Science Foundation of China, one program of Major Program of National Natural Science Foundation of China and one Key Clinical Program of the Ministry of Health. He is the review committee of National Natural Science Foundation of China and ministry of science and technology of china. He got awards such as Innovative Research Team in the University of Ministry of Education of China, the 3rd class of National S&T Progress Awards and the 2nd class of Military progress prize in science and technology.

Consultant Advisors


Dr. Philip Beatty is currently a senior scientist at Synaptive Medical (Toronto, Canada) and an assistant professor in the Department of Medical Biophysics at the University of Toronto. Dr. Beatty received his Ph.D. in Electrical Engineering from Stanford University in 2007. He worked as a development scientist in the Global Applied Science Laboratory at GE Healthcare for five years (Menlo Park, California and Toronto, Canada) and as a research scientist for three years at the Sunnybrook Research Institute (Toronto, Canada). Dr. Beatty’s research focuses on developing image acquisition and reconstruction strategies for Magnetic Resonance Imaging.

Prof. Hua Guo is a principal investigator at Center for Biomedical Imaging Research, Department of Biomedical Engineering at Tsinghua University in Beijing. He received his Ph.D. from the department of Biomedical Engineering at Duke University in 2006. He was an assistant professor in the department of radiology of New York University from 2008 to 2010. Before that he once worked in Siemens as a scientist and at the University of Hong Kong as a postdoc. He has extensive research experience in MRI physics, advanced imaging method development and preclinical studies. His primary research interest focuses on two core areas in MRI. The first one is MRI physics including novel sequence design and image reconstruction, which can potentially provide high spatiotemporal resolution and multi-parametric quantitative imaging. Particularly, he is working on high resolution diffusion weighted imaging at present. The second area is the translational application of advanced MRI techniques for accurate diagnosis and disease management.

Dr. Feng Huang has worked on fast and robust MR imaging for 15 years. Even though he works in Industry (Phillips Healthcare), he continuously contributes to academia. He has published over 40 journal papers, 150 conference papers/abstracts, 28 US patents, and is a reviewer for 12 journals. Multiple research results of him has been implemented in Philips system and widely used. Currently, he leads the clinical solution team in Philips healthcare (Suzhou, China), and collaborates globally to provide clinically meaningful solution packages.

Dr. Juan Wei graduated from the Department of Electrical and Electronic Engineering at the University of Hong Kong in 2007 and worked as a research fellow in the Department of Radiology at Johns Hopkins University. Now as a research scientist at Philips Research China, she participated in MR research collaborations with top universities, key labs and high-level hospitals in China for the MR research project setup and management. This includes coil design, RF sequence design, MR guided HIFU (High Intensity Focused Ultrasound) treatment plan, patient screening and EPSI (Echo Planar Spectroscopy Imaging) application. As a person who has been engaged in clinical, scientific research and industry, she understands the challenges and problems to bridge these three fields.

Dr. Qi Yang, M.D., Associate Chief Physician in Radiology, Associate Professor. He is the winner of National Excellent Doctoral Dissertation, the Outstanding Scholar of National Natural Science Foundation of China, and New Century Excellent Talent. He was elected as Junior Fellow of the International Society of Magnetic Resonance Medical, junior members of the Education Committee, secretary of the International Society of Cardiovascular Magnetic Resonance China Chapter, deputy director of the Chinese Society of Biomedical Engineering Youth Committee. Research interests include: theory of cardiovascular magnetic resonance imaging and clinical application. He published more than 20 journal papers. He edited two textbooks, has two Chinese patents and one software patent. He received multiple awards including International Angio Club James Potchen Award in 2010.

Note:consultant advisors are listed fully in alphabetical order according to the consultant's last name
        

Messages from Advisors


Dr. Chun Yuan:

OCHIS is an important organization that has great potential to enhance research collaborations and further Magnetic Resonance Imaging research, especially for young researchers. As research and industry become more specialized, organizations like OCHIS represent a major opportunity for cross-platform development and pushing the influence of research into industrial and clinical applications. OCHIS will help both young scholars and research as a whole.

Dr. Feng Huang:

It has been a long time that the Chinese in the field of MR expect an easy-to-use communication platform. Previously, a few efforts have been unsuccessfully tried to set up a platform. Now, a group of young scientists organize the “ Overseas Chinese Healthcare Innovator Society”, and start using the most powerful web social tool to set up the multi-functional platform. With these young people with dreams, and the supports from these respectful professors such as Chun Yuan and Debiao Li, I believe the platform will provide numerous opportunities not only for academia, but also for the industry. Let’s start from MR, and further develop it to become a great platform of healthcare to generate scientists, as well as businessmen, and finally benefit our society.

Dr. Juan Wei:

As Chinese economy increasingly develops, the conventional medical imaging could not meet the rapidly growing demand in clinical diagnostics. Creative solutions to how to apply the cutting-edge technologies for the imaging guided therapy (IGP) to clinical settings in China are critically needed. We expect that this platform run by OCHIS is able to enhance international collaborations so that the novel techniques could be commercialized and practically used in clinical settings, from which Chinese patients would actually benefit.

Dr. Qi Yang:

The real value of medical research is not only about publishing but also benefiting more patients. Establishing an effective communication platform for overseas Chinese scholars will foster interdisciplinary research and collaboration. It will accelerate the translation of technologies from bench to bedside and benefit patient care.